Tech Company Financing Transactions

Proteolix Funding Round

On 9/8/2008, Proteolix raised $79 million in Series C investment from Nomura Phase4 Ventures, Advanced Technology Ventures and Delphi Ventures.

Transaction Overview

Company Name
Proteolix
Announced On
9/8/2008
Transaction Type
Venture Equity
Amount
$79,000,000
Round
Series C
Investors

Nomura Phase4 Ventures (Lead Investor) (Denise Pollard-Knight)

Advanced Technology Ventures (Jean George)

Delphi Ventures (Deepa Pakianathan)

Latterell Venture Partners

The Vertical Group (Jack Lasersohn)

U.S. Venture Partners (Jonathan Root)

Proceeds Purpose
Proceeds from the financing will primarily support the completion of the company's ongoing Phase 2 clinical trials of carfilzomib, and the advancement of this anti-cancer therapeutic into Phase 3 clinical trials for the treatment of multiple myeloma. Proteolix will also use the funds to advance candidates in the company's earlier stage pipeline of proteasome inhibitors.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
333 Allerton Avenue
South San Francisco, CA 94080
USA
Phone
650.266.2890
Website
www.proteolix.com
Email Address
[email protected]
Overview
Proteolix, Inc. is a biopharmaceutical company dedicated to discovering, developing and marketing pharmaceutical products that target the proteasome and the control of protein turnover in cells. The company's focus is on the treatment of cancer, inflammatory disease, and autoimmunity.
Profile
Proteolix LinkedIn Company Profile
Social Media
Proteolix Company Twitter Account
Company News
Proteolix News
Facebook
Proteolix on Facebook
YouTube
Proteolix on YouTube

Management Team

Title
Name
Email & Social
Chief Medical Officer
Michael Kauffman
  Michael Kauffman LinkedIn Profile  Michael Kauffman Twitter Account  Michael Kauffman News  Michael Kauffman on Facebook
Executive Vice President
Thomas Kassberg
  Thomas Kassberg LinkedIn Profile  Thomas Kassberg Twitter Account  Thomas Kassberg News  Thomas Kassberg on Facebook
Vice President
Mark Bennett
  Mark Bennett LinkedIn Profile  Mark Bennett Twitter Account  Mark Bennett News  Mark Bennett on Facebook
Vice President
Christopher Molineaux
  Christopher Molineaux LinkedIn Profile  Christopher Molineaux Twitter Account  Christopher Molineaux News  Christopher Molineaux on Facebook
VP - Finance
Craig Parker
  Craig Parker LinkedIn Profile  Craig Parker Twitter Account  Craig Parker News  Craig Parker on Facebook
VP - Regulatory Affairs
Albert Kraus
  Albert Kraus LinkedIn Profile  Albert Kraus Twitter Account  Albert Kraus News  Albert Kraus on Facebook

 

 

Browse more venture capital transactions:

Prev: 9/5/2008: mPay Gateway venture capital transaction
Next: 9/8/2008: Innovative Spinal Technologies venture capital transaction

 

Share this article

 

About Database of VC Transactions

We report on all VC transactions involving tech companies. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.